{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:14:44Z","timestamp":1791213284892,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.nbd.2019.02.016","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T23:16:21Z","timestamp":1550790981000},"page":"142-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Assessment of APOE in atypical parkinsonism syndromes"],"prefix":"10.1016","volume":"127","author":[{"given":"Marya S.","family":"Sabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis","family":"Blauwendraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geidy E.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7635-8645","authenticated-orcid":false,"given":"Lasse","family":"Pihlstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Pantelyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Cookson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena G.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted M.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana S.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pletnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Troncoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-0429","authenticated-orcid":false,"given":"Sonja W.","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nbd.2019.02.016_bb0005","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.46.4.1156","article-title":"Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy","volume":"46","author":"Anouti","year":"1996","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2019.02.016_bb0010","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2006.06.032","article-title":"Effect of MAPT and APOE on prognosis of progressive supranuclear palsy","volume":"405","author":"Baba","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"11","key":"10.1016\/j.nbd.2019.02.016_bb0015","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/jnnp-2013-307228","article-title":"Apolipoprotein E 2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort","volume":"85","author":"Berge","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2019.02.016_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.05.009","article-title":"NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases","volume":"57","author":"Blauwendraat","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2019.02.016_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2051-5960-2-15","article-title":"Lipid dysfunction and pathogenesis of multiple system atrophy","volume":"2","author":"Bleasel","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2019.02.016_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2377-6-31","article-title":"Functional correlates of apolipoprotein E genotype in frontotemporal lobar degeneration","volume":"6","author":"Borroni","year":"2006","journal-title":"BMC Neurol."},{"key":"10.1016\/j.nbd.2019.02.016_bb0035","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"Gigascience"},{"issue":"6","key":"10.1016\/j.nbd.2019.02.016_bb0040","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nrg1871","article-title":"The quest for genetic determinants of human longevity: challenges and insights","volume":"7","author":"Christensen","year":"2006","journal-title":"Nat. Rev. Genet."},{"issue":"5123","key":"10.1016\/j.nbd.2019.02.016_bb0045","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nbd.2019.02.016_bb0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.nbd.2019.02.016_bb0055","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/jnen\/61.11.935","article-title":"Office of rare diseases neuropathologic criteria for corticobasal degeneration","volume":"61","author":"Dickson","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"12","key":"10.1016\/j.nbd.2019.02.016_bb0060","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.nbd.2019.02.016_bb0065","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","article-title":"APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology","volume":"91","author":"Dickson","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nbd.2019.02.016_bb0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.parkreldis.2014.02.012","article-title":"Concomitant pathologies among a spectrum of parkinsonian disorders","volume":"20","author":"Dugger","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.nbd.2019.02.016_bb0075","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.nbd.2012.02.002","article-title":"A large study reveals no association between APOE and Parkinson's disease","volume":"46","author":"Federoff","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"10","key":"10.1016\/j.nbd.2019.02.016_bb0080","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.44.10.1950","article-title":"The apolipoprotein E allele epsi;4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease","volume":"44","author":"Galasko","year":"1994","journal-title":"Neurology"},{"issue":"7571","key":"10.1016\/j.nbd.2019.02.016_bb0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Genomes Project Consortium","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.nbd.2019.02.016_bb0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nbd.2019.02.016_bb0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","article-title":"Cortical Lewy body pathology in the diagnosis of dementia","volume":"102","author":"Harding","year":"2001","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.nbd.2019.02.016_bb0100","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1212\/WNL.44.11.2015","article-title":"Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)","volume":"44","author":"Hauw","year":"1994","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.nbd.2019.02.016_bb0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/ng.859","article-title":"Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy","volume":"43","author":"H\u00f6glinger","year":"2011","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.nbd.2019.02.016_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","article-title":"National institute on aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease","volume":"8","author":"Hyman","year":"2012","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.nbd.2019.02.016_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-014-1380-1","article-title":"Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine","volume":"129","author":"Irwin","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.nbd.2019.02.016_bb0120","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1001\/archneur.61.10.1579","article-title":"Apolipoprotein E \u03b54 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration","volume":"61","author":"Josephs","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2019.02.016_bb0125","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1038\/ncomms8247","article-title":"Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy","volume":"6","author":"Kouri","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.nbd.2019.02.016_bb0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2019.02.016_bb0135","first-page":"193","article-title":"APOE \u03b52 and \u03b54 influence the susceptibility for Alzheimer's disease but not other dementias","volume":"1","author":"Lovati","year":"2010","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"issue":"3 Suppl","key":"10.1016\/j.nbd.2019.02.016_bb0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"9","author":"McKeith","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.nbd.2019.02.016_bb0145","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000065889.42856.F2","article-title":"Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies","volume":"60","author":"Merdes","year":"2003","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.nbd.2019.02.016_bb0150","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1212\/WNL.55.12.1918","article-title":"Multiple system atrophy\/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE","volume":"55","author":"Morris","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nbd.2019.02.016_bb0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0304-3940(01)02190-5","article-title":"Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy","volume":"312","author":"Morris","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.nbd.2019.02.016_bb0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mds.27297","article-title":"Multiple system atrophy and apolipoprotein E","volume":"33","author":"Ogaki","year":"2018","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.nbd.2019.02.016_bb0165","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1006\/exnr.2000.7387","article-title":"Apolipoprotein E \u03f54 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pick- or microvacuolar-type histology","volume":"163","author":"Pickering-Brown","year":"2000","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2019.02.016_bb0170","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"issue":"15","key":"10.1016\/j.nbd.2019.02.016_bb0175","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1212\/WNL.0000000000003221","article-title":"A genome-wide association study in multiple system atrophy","volume":"87","author":"Sailer","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nbd.2019.02.016_bb0180","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.mp.4000285","article-title":"Apolipoprotein E in progressive supranuclear palsy in Japan","volume":"2","author":"Sawa","year":"1997","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.nbd.2019.02.016_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0194-29","article-title":"Genetic associations with human longevity at the APOE and ACE loci","volume":"6","author":"Sch\u00e4chter","year":"1994","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.nbd.2019.02.016_bb0190","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.48.4.959","article-title":"Corticobasal degeneration: neuropathologic and clinical heterogeneity","volume":"48","author":"Schneider","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2019.02.016_bb0195","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/brain\/aws234","article-title":"Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies","volume":"135","author":"Schneider","year":"2012","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.nbd.2019.02.016_bb0200","doi-asserted-by":"crossref","first-page":"24629","DOI":"10.3390\/ijms161024629","article-title":"Genetics underlying atypical parkinsonism and related neurodegenerative disorders","volume":"16","author":"Scholz","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.nbd.2019.02.016_bb0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000066022","article-title":"Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies","volume":"14","author":"Singleton","year":"2002","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2019.02.016_bb0210","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12311","article-title":"Synucleinopathies: past, present and future","volume":"42","author":"Spillantini","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.1016\/j.nbd.2019.02.016_bb0215","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-3940(94)90867-2","article-title":"Apolipoprotein E \u03f54 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls","volume":"176","author":"St Clair","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2019.02.016_bb0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","article-title":"Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain","volume":"62","author":"Sultana","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"9","key":"10.1016\/j.nbd.2019.02.016_bb0225","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1212\/WNL.45.9.1764","article-title":"Apolipoprotein E element 4 allele frequency is not increased in progressive supranuclear palsy","volume":"45","author":"Tabaton","year":"1995","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nbd.2019.02.016_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-510X(98)00099-9","article-title":"No association between apolipoprotein E alleles and olivopontocerebellar atrophy","volume":"158","author":"Toji","year":"1998","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.nbd.2019.02.016_bb0235","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","article-title":"APOE \u03f54 increases risk for dementia in pure synucleinopathies","volume":"70","author":"Tsuang","year":"2013","journal-title":"JAMA Neurol."},{"issue":"7","key":"10.1016\/j.nbd.2019.02.016_bb0240","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jalz.2018.02.005","article-title":"APOE DNA methylation is altered in Lewy body dementia","volume":"14","author":"Tulloch","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.nbd.2019.02.016_bb0245","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives","volume":"18","author":"Van Cauwenberghe","year":"2016","journal-title":"Genet Med."},{"key":"10.1016\/j.nbd.2019.02.016_bb0250","series-title":"Neurological Disorders: Public Health Challenges","author":"World Health Organization","year":"2006"},{"issue":"1","key":"10.1016\/j.nbd.2019.02.016_bb0255","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","article-title":"APOE \u03b52 is associated with increased tau pathology in primary tauopathy","volume":"9","author":"Zhao","year":"2018","journal-title":"Nat. Commun."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119300464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119300464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:14:59Z","timestamp":1760850899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119300464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":51,"alternative-id":["S0969996119300464"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.02.016","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of APOE in atypical parkinsonism syndromes","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}